CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Zepto Systemdevice
Likely dose
Anterior capsulotomy using the Zepto SystemAI-extracted
Key inclusion· 3
  • ✓Age 22 years or older
  • ✓Symptomatic age-related lens cataract requiring phacoemulsification and IOL implant surgery
  • ✓Willing to undergo Zepto capsulotomy and complete 3-month follow-up
Key exclusion· 10
  • ✕Prior ocular surgery in the study eye
  • ✕Zonular abnormality
  • ✕Posterior polar cataract
  • ✕Pupillary dilation less than 7 mm diameter at pre-operative exam

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02890303
NCT02890303N/ACompleted
CompareCT.gov

A Prospective Multi-Center Study of Anterior Lens Capsulotomy Using the Mynosys Zepto System

Mynosys Cellular Devices, Inc.·interventional·Posted Sep 7, 2016·Updated Apr 27, 2018

In Brief

A clinical study evaluating Zepto System for Cataract. Completed, enrolled 100 participants.

Detailed Summary

This study will evaluate outcome in subjects who have elected to have Zepto capsulotomies during cataract surgery with phacoemulsification.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedSep 7, 2016
Enrollment StartSep 12, 2016
Primary CompletionDec 15, 2016
Study CompletionMar 14, 2017
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 9.8 years ago

Interventions

Zepto Systemdevice

Anterior Capsulotomy using the Zepto System.